The University of Chicago Medicine (UChicago Medicine) in the US has deployed Noah Medical’s Galaxy robot system to perform bronchoscopies to enhance the early identification of lung cancer.

The first four cases have been successfully performed at the UChicago Medicine hospital using the new robotic technology.

During a bronchoscopy, a patient is placed under anaesthesia while a long tube with a small camera (scope) is guided through the mouth.

A handheld device, resembling a video game controller, is used by the physician to guide the scope through the lungs.

According to UChicago Medicine pulmonologist Dr Kyle Hogarth, the robot allows the scope to reach potentially cancerous lung nodules and lesions in difficult -to-reach places with significantly enhanced precision and accuracy compared to the current, first-generation robotic scopes.

Hogarth further said: “Even with the first-generation robotic scopes, bronchoscopists might miss a nodule. Now I know exactly where to put that biopsy needle and I get confirmation from the system that the needle is in the right place.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“This will be helpful to anyone with an abnormal CT scan to determine what’s wrong and what we can do next. If a biopsy is needed, we’ll make sure it’s done correctly.”

In March this year, Noah Medical secured approval from the US Food and Drug Administration (FDA) for its Galaxy system.

The system is designed to offer bronchoscopic visualisation of and access to patient airways to conduct diagnostic and therapeutic procedures.

Galaxy robot is integrated with an X-ray-enhanced nodule-targeting system.

The device deploys a disposable, single-use, bronchoscope to reduce the risk of infection or disease transmission.